Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of EDP-978 in healthy adults; currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inducible Urticaria
• Spontaneous Urticaria

Drugs mentioned

• EDP-978

Snippet

Sponsor: Enanta Pharmaceuticals, Inc | Conditions: Chronic Inducible Urticaria, Chronic Spontaneous Urticaria | Phase 1 | Status: RECRUITING